Table 1.
Variable | Controlled, N = 50 | Uncontrolled, N = 50 | P | All, N = 100 |
---|---|---|---|---|
Male | 12 (24%) | 15 (30%) | 0.499 | 27 (27%) |
Female | 38 (76%) | 35 (70%) | 73 (73%) | |
Age | 48.1 ± 7.75 | 46.94 ± 8.96 | 0.490 | 47.52 ± 8.35 |
BMI | 32.7 ± 5.6 | 31 ± 5.22 | 0.119 | 31.85 ± 5.45 |
Smoking | 12 (24%) | 13 (26%) | 0.817 | 25 (25%) |
Duration of HTN | 6.78 ± 4.47 | 6.1 ± 3.73 | 0.411 | 6.44 ± 4.11 |
F. history | 28 (56%) | 27 (54%) | 0.841 | 55 (55%) |
Office systolic | 135.12 ± 19.45 | 143.56 ± 29.4 | 0.087 | 138.58 ± 24.25 |
Office diastolic | 88.53 ± 16.65 | 85.37 ± 15.04 | 0.341 | 87.33 ± 16.05 |
ABPM systolic | 125.15 ± 17.93 | 128.96 ± 25.9 | 0.395 | 126.05 ± 20.42 |
ABPM diastolic | 87.63 ± 18.52 | 86.04 ± 12.47 | 0.616 | 86.84 ± 15.99 |
Night | ||||
Dipper | 36 (72%) | 30 (60%) | 0.205 | 66 (66%) |
Not dipper | 14 (28%) | 20 (40%) | 34 (34%) | |
Central systolic | 126.07 ± 19.41 | 130.63 ± 27.61 | 0.348 | 127.44 ± 22.14 |
Central diastolic | 89.49 ± 17.93 | 88.77 ± 13.89 | 0.831 | 89.21 ± 16.40 |
PWV | 7.25 ± 1.09 | 7.8 ± 1.33 | 0.024* | 7.52 ± 1.24 |
Augmentation index | 24.3 ± 9.71 | 25.84 ± 11.75 | 0.477 | 25.07 ± 10.75 |
MAP | 102.42 ± 16.27 | 98.88 ± 14.53 | 0.254 | 100.65 ± 15.45 |
Cr | 0.8 ± 0.31 | 1.04 ± 0.34 | 0.000** | 0.92 ± 0.35 |
GFR | 118.04 ± 48.29 | 94.88 ± 51.17 | 0.022* | 106.46 ± 50.85 |
LVMI | 0.92 ± 0.12 | 0.95 ± 0.13 | 0.311 | 0.93 ± 0.13 |
EF | 59.34% ± 5.69% | 59.12% ± 5.83% | 0.849 | 59.23% ± 5.73% |
CIMT | 0.7 ± 0.12 | 0.77 ± 0.14 | 0.008** | 0.74 ± 0.13 |
ABI | 0.91 ± 0.2 | 0.95 ± 0.27 | 0.322 | 0.93 ± 0.24 |
BMI body mass index, HTN hypertension, ABPM ambulatory blood pressure monitoring, PWV pulse wave velocity, MAP mean arterial pressure, Cr creatinine, GFR glomerular filtration ratio, LVMI left ventricular mass index, EF ejection fraction, CIMT carotid intimal thickness, ABI ankle brachial index
* Statistically significant difference (p < 0.05), **highly statistically significant difference (p < 0.01)